Carpal Tunnel Release

Both techniques have equivalent long-term outcomes, with 75-90% of patients achieving complete or near-complete symptom relief. Endoscopic may offer slightly faster return to work and less scar tenderness due to the smaller palmar incision. Open release provides direct visualization and may be preferred in revision cases or atypical anatomy. The difference is marginal—surgeon experience with their preferred technique matters more than the technique itself. Patient satisfaction rates (88%) are similar for both approaches.

Yes, bilateral carpal tunnel release is commonly performed in a single session, particularly for medical tourists. Recovery may be slightly more challenging (difficulty with gripping and personal care for 1-2 weeks), but it avoids a second procedure and recovery period. Many patients manage well with bilateral release, especially with the WALANT technique. Studies show 81.6% of patients would undergo the same procedure again.

Tingling and night symptoms often improve within days to weeks. Numbness recovery depends on severity and duration of compression: mild CTS recovers within weeks; moderate CTS within 2-3 months; severe CTS with muscle wasting may take 6-12 months for partial improvement, and some permanent numbness may remain. This is why early surgery is recommended for progressive or severe symptoms.

WALANT (Wide-Awake Local Anesthesia No Tourniquet) uses local anesthetic with epinephrine injected into the hand. The patient remains awake and can move their fingers during surgery, allowing the surgeon to confirm complete release and check tendon function. Benefits include no sedation risks, no tourniquet discomfort, immediate finger movement, and faster discharge. Studies show 90% of WALANT patients would choose this technique again, and only 5% require opioid pain medication post-operatively.

True recurrence requiring revision surgery is uncommon (0.3-7%), though 3-19% of patients may experience some degree of symptom recurrence or persistence. If symptoms recur, it may indicate incomplete initial release, scar tissue formation, or new pathology. True recurrence is distinguished from persistent symptoms when the nerve was too damaged to fully recover. Revision surgery or neurolysis can be performed if needed. Ergonomic modifications and activity changes help prevent recurrence.

Best outcomes occur in patients with short symptom duration (less than 12 months), mild-to-moderate CTS, no thenar atrophy, absence of diabetes, non-smokers, and no workers' compensation involvement. Patients with these favorable characteristics have success rates approaching 90%. Those with risk factors may still benefit from surgery but should have realistic expectations about potential for incomplete symptom resolution.